4//SEC Filing
Beeler Brian K 4
Accession 0001209191-21-056671
CIK 0001492426other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 5:06 PM ET
Size
5.6 KB
Accession
0001209191-21-056671
Insider Transaction Report
Form 4
Beeler Brian K
EVP, General Counsel
Transactions
- Sale
Ordinary Shares
2021-09-17$107.91/sh−28,143$3,036,911→ 62,775 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2021.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.45 to $108.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Horizon Therapeutics Public Ltd Co
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001641580
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 5:06 PM ET
- Size
- 5.6 KB